Healthcare Analysts discuss Penumbra (PEN) STORM-PE Data on an Analyst/Industry conference call to be held on November 4.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEN:
- Penumbra Inc. Launches i-RISE Study to Enhance Stroke Treatment Insights
- Penumbra Inc.’s STRIKE-PE Study: A Game Changer for Pulmonary Embolism Treatment?
- Penumbra Inc.’s STRIDE II Study: A Promising Update for Investors
- Penumbra Inc.’s BOLT Study: A Game-Changer for Deep Vein Thrombosis Treatment?
- Penumbra reports positive results of vacuum thrombectomy in embolism trial